Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates
Melissa J MacPherson, Sarah L. Erickson, Drayden Kopp, Pengqiang Wen, Mohamad‐Reza Aghanoori, Shreeya Kedia, Kaylan M.L. Burns, Antonio Vitobello, Frédéric Tran Mau‐Them, Quentin Thomas, Nina B. Gold, William Brucker, Louise Amlie‐Wolf, Karen W. Gripp, Olaf A. Bodamer, Laurence Faivre, Mikko Muona, Lara Menzies, Júlia Baptista, Katie Guegan, Alison Male, Xing‐Chang Wei, Guiqiong He, Quan Long, A. Micheil Innes, Guang Yang
Abstract
The development of the cerebral cortex requires balanced expansion and differentiation of neural stem/progenitor cells (NPCs), which rely on precise regulation of gene expression. Because NPCs often exhibit transcriptional priming of cell-fate-determination genes, the ultimate output of these genes for fate decisions must be carefully controlled in a timely fashion at the post-transcriptional level, but how that is achieved is poorly understood. Here, we report that de novo missense variants in an RNA-binding protein CELF2 cause human cortical malformations and perturb NPC fate decisions in mice by disrupting CELF2 nucleocytoplasmic transport. In self-renewing NPCs, CELF2 resides in the cytoplasm, where it represses mRNAs encoding cell fate regulators and neurodevelopmental disorder-related factors. The translocation of CELF2 into the nucleus releases mRNA for translation and thereby triggers NPC differentiation. Our results reveal that CELF2 translocation between subcellular compartments orchestrates mRNA at the translational level to instruct cell fates in cortical development.